1. Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers. (1st September 2014) Authors: Berger, C.; Almohareb, O.; Langsetmo, L.; Hanley, D.A.; Kovacs, C.S.; Josse, R.G.; Adachi, J.D.; Prior, J.C.; Towheed, T.; Davison, K.S.; Kaiser, S.M.; Brown, J.P.; Goltzman, D.; the CaMos Research Group Journal: Clinical endocrinology Issue: Volume 82:Number 3(2015:Mar.) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The association between sclerostin and incident type 2 diabetes risk: a cohort study. (26th January 2017) Authors: Yu, O.H.Y.; Richards, B.; Berger, C.; Josse, R.G.; Leslie, W.D.; Goltzman, D.; Kaiser, S.M.; Kovacs, C.S.; Davison, K.S. Journal: Clinical endocrinology Issue: Volume 86:Number 4(2017) Page Start: 520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗